Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

The Active Patient: Faces Of Change

February 1, 2014

Advocacy organizations and individual patients are getting more involved in every facet of the healthcare system, from drug R&D, to federal and state policy all fueled by the hour-to-hour passion of living with a disease.

Senior Execs' Anti-Social Media Behavior

January 28, 2014

Recent research says social media and messaging apps are continuing to proliferate. But not so with senior execs, who are starting to avoid these networks altogether, says Chris Molloy.

2014: The Year of Digital Pharma?

January 23, 2014

2014 might be the year that pharma finally has to get really serious about digital, at least if the analysts are right. Peter Houston reports.

Russia's Bet on Biopharma

January 21, 2014

Can innovation trump ideology? Russia faces a stark choice in betting on the visible hand of government in promoting a "world class" biopharmaceutical sector, writes William Looney.

Biosimilars or Bust

January 21, 2014

Where are the biosimilars to help cut costs as the first wave of biologics, or complex, small molecule respiratory drugs, for example, go off patent? They've arrived in Europe, but the U.S. lags...

Innovation: The Moneyball Test

January 21, 2014

Successful innovation now has to align with key metrics of value—can an old baseball metaphor help guide the way?

Pharm Exec's Annual Industry Outlook 2014

January 21, 2014

For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive — muddling through is so yesterday.

Social Media: Have We Reached the Tipping Point?

January 20, 2014

FDA has released its draft guidance on the use of Interactive Promotional Media, finally providing the industry with substantial guidance on its use of digital media.

R&D in Transition

January 17, 2014

If R&D doesn't rebound, the growth prospects of R&D services providers will suffer, and even commercial CMOs will see fewer opportunities coming their way, writes Jim Miller.

ADVERTISEMENT

Click here